Epstein-Barr virus

Merck pays $50 million for early-stage Epstein-Barr vaccine
BioPharma Dive
Wed, 03/8/23 - 09:49 pm
Merck
OPKO Health
vaccines
Epstein-Barr virus
As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine
Endpoints
Fri, 10/21/22 - 10:22 am
Epstein-Barr virus
vaccines